Drug Database
Back to search

Netherlands· NL-894ebf41a337

Dexamytrex Ophtiole 1 en 5 mg/ml oogdruppels, oplossing

A dexamethason mit antiinfektiva product containing dexamethasondinatriumfosfaat + gentamicinesulfaat, registered in Netherlands by Bausch + Lomb Ireland Limited. The same ATC class is registered in 11 of our 19 countries.

ATC S01CA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDexamytrex Ophtiole 1 en 5 mg/ml oogd…ATCS01CA01REGISTER NO.NL-894ebf41a337PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dexamethasondinatriumfosfaat + gentamicinesulfaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dexamethason mit antiinfektiva is registered in 11 of 19 countries.

Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search dexamethason mit antiinfektiva products by name

Dexamethason mit antiinfektiva · ATC S01CA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DEXAMETHASONDINATRIUMFOSFAAT + GENTAMICINESULFAAT
Manufacturer
Bausch + Lomb Ireland Limited
Country
Netherlands (NL)
ATC code
S01CA01
ATC class
Dexamethason mit Antiinfektiva
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    11302

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under S01CA01

Dexamethason mit antiinfektiva, as other registers publish it.

All dexamethason mit antiinfektiva products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/883360dc-6bea-4258-8b46-d13d8760fda1
GET /v1/drugs/883360dc-6bea-4258-8b46-d13d8760fda1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h11302_smpc.pdf",
  "strength": null,
  "atc_label": "Dexamethasone And Antiinfectives",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg11302",
  "excipients": [
    "CETRIMIDE",
    "DINATRIUMEDETAAT 2-WATER",
    "DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
    "GLYCEROL 85 PER CENT (E 422)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMMETABISULFIET (E 223)",
    "POVIDON K 25 (E 1201)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "DEXAMETHASONDINATRIUMFOSFAAT",
    "GENTAMICINESULFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h11302.pdf",
  "authorised_at": "1987/07/22",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "11302",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about dexamethason mit antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console